This naturally suggested the use of the multi-kinase inhibitor SOR (approved for the treatment of HCC) given reports of it targeting of XC ̄(SLC7A11) to trigger ferroptosis [19, 29]. The gene discussed is SLC7A11; the disease is hepatocellular carcinoma.